138 related articles for article (PubMed ID: 28492539)
1. Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.
Zhao Y; Lai Y; Ge H; Guo Y; Feng X; Song J; Wang Q; Fan L; Peng Y; Cao M; Harris AL; Wang X; Tao L
Cell Death Dis; 2017 May; 8(5):e2773. PubMed ID: 28492539
[TBL] [Abstract][Full Text] [Related]
2. Cx32 inhibits TNFα-induced extrinsic apoptosis with and without EGFR suppression.
Lai Y; Tao L; Zhao Y; Zhang X; Sun X; Wang Q; Xu C
Oncol Rep; 2017 Nov; 38(5):2885-2892. PubMed ID: 28901517
[TBL] [Abstract][Full Text] [Related]
3. Cx32 suppresses extrinsic apoptosis in human cervical cancer cells via the NF‑κB signalling pathway.
Lai Y; Fan L; Zhao Y; Ge H; Feng X; Wang Q; Zhang X; Peng Y; Wang X; Tao L
Int J Oncol; 2017 Oct; 51(4):1159-1168. PubMed ID: 28902345
[TBL] [Abstract][Full Text] [Related]
4. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.
Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L
J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731
[TBL] [Abstract][Full Text] [Related]
5. Connexins and apoptotic transformation.
Kalvelyte A; Imbrasaite A; Bukauskiene A; Verselis VK; Bukauskas FF
Biochem Pharmacol; 2003 Oct; 66(8):1661-72. PubMed ID: 14555247
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl tail of connexin32 regulates gap junction assembly in human prostate and pancreatic cancer cells.
Katoch P; Mitra S; Ray A; Kelsey L; Roberts BJ; Wahl JK; Johnson KR; Mehta PP
J Biol Chem; 2015 Feb; 290(8):4647-4662. PubMed ID: 25548281
[TBL] [Abstract][Full Text] [Related]
7. The cytoplasmic translocation of Cx32 mediates cisplatin resistance in ovarian cancer cells.
Wu W; Fan L; Bao Z; Zhang Y; Peng Y; Shao M; Xiang Y; Zhang X; Wang Q; Tao L
Biochem Biophys Res Commun; 2017 May; 487(2):292-299. PubMed ID: 28412364
[TBL] [Abstract][Full Text] [Related]
8. Cx32 promotes autophagy and produces resistance to SN‑induced apoptosis via activation of AMPK signalling in cervical cancer.
Fan LX; Tao L; Lai YC; Cai SY; Zhao ZY; Yang F; Su RY; Wang Q
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34970699
[TBL] [Abstract][Full Text] [Related]
9. The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression.
Aasen T; Hodgins MB; Edward M; Graham SV
Oncogene; 2003 Sep; 22(39):7969-80. PubMed ID: 12970745
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt-β-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma.
Chakraborty C; Samadder S; Roychowdhury A; Roy A; Das P; Mandal RK; Roychoudhury S; Panda CK
Mol Cell Biochem; 2018 Jun; 443(1-2):121-130. PubMed ID: 29079964
[TBL] [Abstract][Full Text] [Related]
11. Differential control of connexin-32 and connexin-43 expression in thyroid epithelial cells: evidence for a direct relationship between connexin-32 expression and histiotypic morphogenesis.
Munari-Silem Y; Guerrier A; Fromaget C; Rabilloud R; Gros D; Rousset B
Endocrinology; 1994 Aug; 135(2):724-34. PubMed ID: 8033821
[TBL] [Abstract][Full Text] [Related]
12. IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients.
Roychowdhury A; Samadder S; Indra Mazumder D; Das P; Basu M; Mondal R; Roy A; Roychoudhury S; Panda CK
Biochem Genet; 2019 Oct; 57(5):638-651. PubMed ID: 30949792
[TBL] [Abstract][Full Text] [Related]
13. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
14. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
Sato H; Fukumoto K; Hada S; Hagiwara H; Fujimoto E; Negishi E; Ueno K; Yano T
Cancer Chemother Pharmacol; 2007 Aug; 60(3):449-57. PubMed ID: 17569045
[TBL] [Abstract][Full Text] [Related]
15. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development.
Chakraborty C; Roychowdhury A; Samadder S; Roy A; Mandal RK; Basu P; Roychoudhury S; Panda CK
Biochem J; 2016 Oct; 473(19):3221-36. PubMed ID: 27458253
[TBL] [Abstract][Full Text] [Related]
16. [Decreased expression of Cx32 and Cx43 and their function of gap junction intercellular communication in gastric cancer].
Wu J; Zhou HF; Wang CH; Zhang B; Liu D; Wang W; Sui GJ
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):742-7. PubMed ID: 18396685
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels.
Narayanan R; Kim HN; Narayanan NK; Nargi D; Narayanan B
Int J Oncol; 2012 Jan; 40(1):13-20. PubMed ID: 21946890
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
19. Hormonal regulation and cellular distribution of connexin 32.2 and connexin 32.7 RNAs in the ovary of Atlantic croaker.
Chang X; Patiño R; Yoshizaki G; Thomas P; Lee VH
Gen Comp Endocrinol; 2000 Nov; 120(2):146-56. PubMed ID: 11078626
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
